Crexendo vs SurgePays
CXDO and SURG side by side, both in telephone communications. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CXDO and SURG compare
Crexendo is the larger company, worth 22 times as much as SurgePays ($164M against $7.5M).
Crexendo keeps more of each dollar of sales as profit, with a net margin of 5.3% compared with −47.9% at SurgePays.
Crexendo scores higher on the StockData Score (12 against 1 for SurgePays), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CXDO | SURG |
|---|---|---|
| Size and price | ||
| Market cap | $164M | $7.5M |
| Share price | $4.92 | $0.141 |
| Change, 1 year | −33.4% | −94.2% |
| Change, 5 years | −6.5% | −93.9% |
| Beta (5Y) | 1.18 | 0.61 |
| Employees | 193 | 30 |
| StockData Score | ||
| Total score | 12 (better) | 1 |
| Valuation score | 2 (better) | 1 |
| Growth score | 3 (better) | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 6 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 35.1× | – |
| P/S | 2.0× | 0.1× (better) |
| P/B | 2.1× | – |
| EV/EBITDA | 35.1× | – |
| Fair value | $3.95 | – |
| Margin of safety | −24.4% | – |
| Growth | ||
| Revenue growth (TTM) | 25.5% | – |
| Revenue growth, 5Y average | 33.0% (better) | 0.92% |
| Net income growth (TTM) | 40.5% | – |
| EPS growth (TTM) | 40.0% | – |
| EPS growth, 5Y average | −19.0% | – |
| Profitability | ||
| Gross margin | – | −19.6% |
| Operating margin | 4.9% (better) | −41.0% |
| Net margin | 5.3% (better) | −47.9% |
| Return on equity | 6.3% | – |
| Return on invested capital | 7.8% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −15.3× |
| Current ratio | 2.06 (better) | 0.19 |
| Altman Z-score | 4.31 (better) | −21.51 |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 39.2% | 4.4% |
| Held by insiders | 72.4% | 9.2% |
| Insider net buying, 12 months | −$25.9M | $83.0K (better) |
| Short interest, % of float | 11.2% | 9.1% |
Go deeper
- CXDO stock overview
- CXDO income statement
- CXDO valuation and score
- SURG stock overview
- SURG income statement
- SURG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.